Acrivon TherapeuticsACRV
13F holders, Q2 2024 (June 30)55holders +7
10new positions
5sold out
2famous investors
$5.80avg. 13F price*
At the end of Q2 2024, 55 institutions reported holding Acrivon Therapeutics Inc. (ACRV) in their 13F filings, up 7 from Q1 2024. 10 opened new positions and 5 sold out. The largest holders were Ra Capital Management, L.P. ($48.4M), Perceptive Advisors LLC ($31.1M) and Sands Capital Alternatives, LLC ($12.3M). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Acrivon Therapeutics Inc.
- CUSIP
- 004890109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $4.6M |
| Exits | 5 | $899K |
All 13F filers, Q1 2024 → Q2 2024: 8,427,636 shares bought and 220,857 shares sold, net +8,206,779 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 55 holders
| Ra Capital Management, L.P. | 0.64% | Add +73.4% | 8,340,508 | $48.4M |
| Perceptive Advisors LLC | 0.75% | Add +78.2% | 5,360,858 | $31.1M |
| Sands Capital Alternatives, LLC | 4.12% | Add +28.4% | 2,122,605 | $12.3M |
| Citadel Advisors | 0.01% | Add +26.2% | 2,119,646 | $12.3M |
| Marshall Wace, LLP | 0.01% | Add +58.8% | 948,866 | $5.5M |
| Wellington Management Group LLP | 0.00% | No change | 888,130 | $5.2M |
| BlackRock Inc. | 0.00% | Add +3.1% | 767,020 | $4.4M |
| Vanguard Group Inc. | 0.00% | Add +47.0% | 745,510 | $4.3M |
| Paradigm Biocapital Advisors LP | 0.15% | New | 659,724 | $3.8M |
| Geode Capital Management, LLC | 0.00% | Add +27.0% | 308,393 | $1.8M |
| State Street Corp. | 0.00% | Add +34.0% | 178,663 | $1.0M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +86.0% | 143,958 | $835K |
| DAFNA Capital Management LLC | 0.17% | Reduce -7.6% | 121,351 | $704K |
| Northern Trust Corp. | 0.00% | Add +5.8% | 114,053 | $662K |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.02% | Reduce -17.1% | 105,249 | $610K |
| Bridgeway Capital Management, LLC | 0.01% | No change | 58,181 | $337K |
| Renaissance Technologies | 0.00% | Reduce -46.9% | 54,500 | $316K |
| Baker Bros. Advisors LP | 0.00% | No change | 52,885 | $307K |
| Exchange Traded Concepts, LLC | 0.01% | Reduce -23.7% | 42,864 | $249K |
| Bank of New York Mellon Corp | 0.00% | Add +50.0% | 36,632 | $212K |
| Jane Street Group, LLC | 0.00% | New | 30,714 | $178K |
| Bank of America Corp. | 0.00% | Add +356.2% | 27,550 | $160K |
| Goldman Sachs Group Inc. | 0.00% | New | 24,384 | $141K |
| Barclays PLC | 0.00% | Add +3.3% | 22,033 | $128K |
| Morgan Stanley | 0.00% | Add +0.0% | 17,249 | $100K |
| Squarepoint Ops LLC | 0.00% | New | 17,207 | $100K |
| Rhumbline Advisers | 0.00% | Add +48.9% | 16,209 | $94K |
| Marex Group Ltd | 0.00% | New | 13,187 | $76K |
| Walleye Capital LLC | 0.00% | New | 12,721 | $74K |
| Occudo Quantitative Strategies LP | 0.01% | New | 12,552 | $73K |
| Nuveen Asset Management, LLC | 0.00% | No change | 11,821 | $69K |
| UBS Group AG | 0.00% | Reduce -12.5% | 11,152 | $65K |
| AAF Wealth Management, LLC | 0.03% | No change | 10,678 | $62K |
| XTX Topco Ltd | 0.01% | New | 10,493 | $61K |
| Dimensional Fund Advisors LP | 0.00% | New | 10,066 | $58K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | — | 6,508 | $38K |
| Corebridge Financial, Inc. | 0.00% | — | 6,355 | $37K |
| JPMorgan Chase & Co. | 0.00% | Add +5.7% | 5,243 | $30K |
| Wells Fargo & Company | 0.00% | Add +20.8% | 5,191 | $30K |
| Citigroup Inc. | 0.00% | Add +12.0% | 5,082 | $29K |
| Osaic Holdings, Inc. | 0.00% | No change | 5,080 | $29K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +362.6% | 3,779 | $22K |
| New York State Common Retirement Fund | 0.00% | Add +1.8% | 2,314 | $13K |
| FMR LLC | 0.00% | Add +60.5% | 1,648 | $10K |
| Russell Investments Group, Ltd. | 0.00% | Add +424.2% | 1,169 | $7K |
| Royal Bank of Canada | 0.00% | Add +301.4% | 1,116 | $6K |
| California State Teachers Retirement System | 0.00% | Reduce -30.2% | 856 | $5K |
| Legal & General Group Plc | 0.00% | No change | 839 | $5K |
| STRS Ohio | 0.00% | No change | 800 | $5K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 695 | $4K |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 400 | $2K |
| Amalgamated Bank | 0.00% | No change | 378 | $2K |
| Cwm, LLC | 0.00% | Add +666.7% | 23 | $0 |
| Capital Advisors, Ltd. LLC | 0.00% | No change | 48 | $0 |
| Avion Wealth | 0.00% | No change | 88 | $0 |
"% of holder's portfolio" is ACRV's weight in each manager's 13F, not the share of Acrivon Therapeutics Inc. the manager owns.